Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over

NICE guideline
Reference number: NG36
Published: 10 February 2016
Last updated: 06 June 2018

Upper aerodigestive tract cancer: confidentiality form

Upper aerodigestive tract cancer: confidentiality form

Upper aerodigestive tract cancer: confidentiality form
03 September 2015
(39.62 Kb 11 sec)

Word Viewer may be required.

Word Viewer may be required.

This page was last updated: 03 September 2015

Equality impact assessment Section 1 (PDF 68 KB)

Published:

30 March 2016
Equality impact assessment Section 2 (PDF 77 KB)

Published:

30 March 2016
Equality impact assessment Section 3 (PDF 69 KB)

Published:

30 March 2016
Consultation comments and responses (PDF 477 KB)

Published:

26 February 2016
Committee member list (PDF 89 KB)

Published:

10 February 2016
Minutes 13 (PDF 90 KB)

Published:

26 February 2016
Draft guideline (NICE) (PDF 334 KB)

Published:

03 September 2015
Full guideline (PDF 4.24 MB)

Published:

03 September 2015
Appendices A-G (PDF 2.72 MB)

Published:

03 September 2015
Appendix H (PDF 11.66 MB)

Published:

03 September 2015
Comments form (MSWord 61 KB)

Published:

03 September 2015
Equality impact assessment (PDF 160 KB)

Published:

03 September 2015
Confidentiality form (MSWord 40 KB)

Published:

03 September 2015
Review questions (PDF 185 KB)

Published:

31 July 2015
Search strategies (PDF 378 KB)

Published:

31 July 2015
Economic plan (PDF 21 KB)

Published:

31 July 2015
List of registered stakeholders (PDF 34 KB)

Published:

04 September 2015
GDG member list (PDF 76 KB)

Published:

21 January 2014
GDG minutes 11 (PDF 85 KB)

Published:

25 June 2015
GDG minutes 10 (PDF 91 KB)

Published:

22 May 2015
GDG minutes 9 (PDF 92 KB)

Published:

19 March 2015
GDG minutes 8 (PDF 71 KB)

Published:

02 February 2015
GDG minutes 7 (PDF 18 KB)

Published:

20 January 2015
GDG minutes 6 (PDF 97 KB)

Published:

06 November 2014
GDG minutes 5 (PDF 94 KB)

Published:

25 September 2014
GDG minutes 4 (PDF 35 KB)

Published:

27 August 2014
GDG minutes 3 (PDF 32 KB)

Published:

28 May 2014
GDG minutes 2 (PDF 33 KB)

Published:

28 May 2014
GDG minutes 1 (PDF 138 KB)

Published:

20 February 2014
Final scope (PDF 180 KB)

Published:

29 November 2013
Scope consultation comments table (PDF 302 KB)

Published:

29 November 2013
Draft scope (PDF 181 KB)

Published:

27 September 2013
Stakeholder scoping workshop notes (PDF 30 KB)

Published:

02 October 2013
List of registered stakeholders (PDF 34 KB)

Published:

04 September 2015